Cited by 850Proteoglycans and glycosaminoglycans researchImmune Response and InflammationAdvanced Glycation End Products research

The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages

Open access
Schaefer, Liliana, Babelova, Andrea, Kiss, Eva, Hausser, Heinz-J., Baliova, Martina, Krzyzankova, Miroslava, Marsche, Gunther, Young, Marian F. +5 more·2005·Journal of Clinical Investigation

Abstract

Biglycan, a small leucine-rich proteoglycan, is a ubiquitous ECM component; however, its biological role has not been elucidated in detail. Here we show that biglycan acts in macrophages as an endogenous ligand of TLR4 and TLR2, which mediate innate immunity, leading to rapid activation of p38, ERK, and NF-kappaB and thereby stimulating the expression of TNF-alpha and macrophage inflammatory protein-2 (MIP-2). In agreement, the stimulatory effects of biglycan are significantly reduced in TLR4-mutant (TLR4-M), TLR2-/-, and myeloid differentiation factor 88-/- (MyD88-/-) macrophages and completely abolished in TLR2-/-/TLR4-M macrophages. Biglycan-null mice have a considerable survival benefit in LPS- or zymosan-induced sepsis due to lower levels of circulating TNF-alpha and reduced infiltration of mononuclear cells in the lung, which cause less end-organ damage. Importantly, when stimulated by LPS-induced proinflammatory factors, macrophages themselves are able to synthesize biglycan. Thus, biglycan, upon release from the ECM or from macrophages, can boost inflammation by signaling through TLR4 and TLR2, thereby enhancing the synthesis of TNF-alpha and MIP-2. Our results provide evidence for what is, to our knowledge, a novel role of the matrix component biglycan as a signaling molecule and a crucial proinflammatory factor. These findings are potentially relevant for the development of new strategies in the treatment of sepsis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci23755

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ECM-bioscaffold degradation products function as DAMPs that ligate pattern-recognition and scavenger receptors on dendritic cells and macrophages; in some contexts they also signal via integrins.

    “ECM-bioscaffold degradation products function as damage-associated molecular patterns (DAMPs) that ligate pattern-recognition and scavenger receptors on dendritic cells and macrophages; in some contexts, they also signal via integrins [2,26,28,29].”

    From Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review (2025) · cites this paper as [29]

    The Discussion reports that ECM-derived biglycan can be liberated during inflammation and signal through TLR4 and TLR2 in macrophages; the Introduction also reports biglycan binding to a macrophage scavenger receptor. The Discussion mentions hyaluronan-derived oligosaccharides activating TLR4, but the paper does not establish the claim for ECM-bioscaffold degradation products generally or support the integrin-signaling clause. It specifies that intact biglycan, rather than its isolated glycosaminoglycan chains, delivered the macrophage proinflammatory signal. Page numbers are not available in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • There is evidence for a role of TLR2 and/or TLR4 in the induction of cytokine and chemokine production in response to extracellular matrix components, including hyaluronan fragments or soluble proteoglycan components, in vitro and in vivo.

    “For example, there is evidence for a role of TLR2 and/or TLR4 in the induction of cytokine and chemokine production in response to extracellular matrix components, including hyaluronan fragments or soluble proteoglycan components, in vitro and in vivo31–34.”

    From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [33]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schaefer, L., Babelova, A., Kiss, E., Hausser, H.-J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Götte, M., Malle, E., Schaefer, R. M., & Gröne, H.-J.
Affiliations
  • University of Münster (DE)
  • Universität Ulm (DE)
  • Medical University of Graz (AT)
  • National Institutes of Health (US)
  • German Cancer Research Center (DE)
Corresponding author
Schaefer, Liliana
Venue
Journal of Clinical Investigation
Published
2005-08-01
Volume
115
Issue
8
Pages
2223-2233
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1987383242
Cited by
850
References
59
Citations by year
2026: 22 · 2025: 35 · 2024: 16 · 2023: 35 · 2022: 40 · 2021: 49 · 2020: 44 · 2019: 34 · 2018: 44 · 2017: 41 · 2016: 49 · 2015: 52 · 2014: 49 · 2013: 49 · 2012: 56
FWCI
11.65
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Massachusetts Institute of Technology
  • Deutsches Krebsforschungszentrum
  • Deutsche Forschungsgemeinschaft (SFB 492, SFB405)
  • Austrian Science Fund (P17013)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
biglycan, small leucine-rich proteoglycans, extracellular matrix, TLR4, TLR2, macrophages, innate immunity, pro-inflammatory signaling, TNF-α, CXCL2, NF-κB, p38 MAPK, ERK, sepsis, LPS, zymosan, MyD88, endogenous ligands
MeSH terms
Animals, Antigens, Differentiation, Extracellular Matrix, Inflammation, Lipopolysaccharides, Lung, Membrane Glycoproteins, Proteoglycans, Receptors, Cell Surface, Receptors, Immunologic, Tumor Necrosis Factor-alpha, Zymosan, Signal Transduction, Extracellular Matrix Proteins, NF-kappa B, Macrophages, Alveolar, Mice, Knockout, Sepsis, p38 Mitogen-Activated Protein Kinases, Adaptor Proteins, Signal Transducing, Toll-Like Receptors, Toll-Like Receptor 2, Toll-Like Receptor 4, Mice, Myeloid Differentiation Factor 88, Biglycan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review